Business Description
Shattuck Labs is a US-based biotech company focused on developing treatments for inflammatory and immune-related conditions. Its lead programs center on blocking a specific protein pathway linked to inflammation, with one drug candidate currently in early human trials and another in advanced pre-clinical testing. The company is also exploring a range of experimental therapies for conditions such as inflammatory bowel disease, alongside a separate cancer-focused research program. Founded in 2016 and based in Austin, Texas, Shattuck Labs is working to build a pipeline of targeted treatments across both inflammation and oncology.
